mitoxantrone has been researched along with Tourette Syndrome in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Tourette Syndrome: A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)
Excerpt | Relevance | Reference |
---|---|---|
" Pediatric Multiple Sclerosis seems to respond better to immunosuppressant agents (Mitoxantrone, Cyclophosphamide, Natalizumab), as well as Neuromyelitis optica (Rituximab, Mycofenolate)." | 4.91 | The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. ( Cocuzza, S; Di Mauro, P; Falsaperla, R; Ledda, C; Lubrano, R; Matin, N; Pavone, P; Serra, A; Tabatabaie, O; Vitaliti, G, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vitaliti, G | 1 |
Tabatabaie, O | 1 |
Matin, N | 1 |
Ledda, C | 1 |
Pavone, P | 1 |
Lubrano, R | 1 |
Serra, A | 1 |
Di Mauro, P | 1 |
Cocuzza, S | 1 |
Falsaperla, R | 1 |
1 review available for mitoxantrone and Tourette Syndrome
Article | Year |
---|---|
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.
Topics: Autoimmune Diseases; Child; Chorea; Cyclophosphamide; Guillain-Barre Syndrome; Humans; Immunoglobuli | 2015 |